Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Theseus Pharmaceuticals, Inc. (THRX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Theseus Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1745020.
Total stock buying since 2021: $36,150,328.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $80,346.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 1,659,864 | $5,006,584 | 0 | $0 | 251,084 | $80,346 |
| 2022 | 416,268 | $4,088,364 | 0 | $0 | 0 | $0 |
| 2021 | 1,692,695 | $27,055,380 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-11 | 0 | $0 | 0 | $0 | 251,084 | $80,346 |
| 2023-07 | 1,659,864 | $5,006,584 | 0 | $0 | 0 | $0 |
| 2022-12 | 10,000 | $49,990 | 0 | $0 | 0 | $0 |
| 2022-01 | 406,268 | $4,038,374 | 0 | $0 | 0 | $0 |
| 2021-12 | 4,570 | $45,380 | 0 | $0 | 0 | $0 |
| 2021-10 | 1,688,125 | $27,010,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-06 | Shakespeare William (See Remarks) | Option Ex | 251,084 | .32 | 80,346 |
| 2023-07-17 | Orbimed Capital Gp Vii Llc | Buy | 479,932 | 3.05 | 1,463,792 |
| 2023-07-17 | Tananbaum James B. (10% Owner) | Buy | 700,000 | 2.97 | 2,079,000 |
| 2023-07-17 | Gordon Carl L | Buy | 479,932 | 3.05 | 1,463,792 |
| 2022-12-30 | Hayden Donald J Jr | Buy | 9,900 | 5.00 | 49,490 |
| 2022-12-29 | Hayden Donald J Jr | Buy | 100 | 5.00 | 500 |
| 2022-01-21 | Orbimed Genesis Gp Llc | Buy | 111,896 | 9.97 | 1,115,603 |
| 2022-01-21 | Gordon Carl L | Buy | 111,896 | 9.97 | 1,115,603 |
| 2022-01-20 | Orbimed Genesis Gp Llc | Buy | 35,000 | 9.95 | 348,250 |
| 2022-01-20 | Gordon Carl L | Buy | 35,000 | 9.95 | 348,250 |
| 2022-01-19 | Orbimed Genesis Gp Llc | Buy | 11,521 | 9.97 | 114,864 |
| 2022-01-19 | Gordon Carl L | Buy | 11,521 | 9.97 | 114,864 |
| 2022-01-13 | Orbimed Genesis Gp Llc | Buy | 17,320 | 9.43 | 163,327 |
| 2022-01-13 | Gordon Carl L | Buy | 17,320 | 9.43 | 163,327 |
| 2022-01-12 | Orbimed Genesis Gp Llc | Buy | 18,897 | 10.06 | 190,103 |
| 2022-01-12 | Gordon Carl L | Buy | 18,897 | 10.06 | 190,103 |
| 2022-01-11 | Orbimed Genesis Gp Llc | Buy | 8,500 | 10.24 | 87,040 |
| 2022-01-11 | Gordon Carl L | Buy | 8,500 | 10.24 | 87,040 |
| 2021-12-21 | Dahms Bradford D. (Chief Financial Officer) | Buy | 1,970 | 10.15 | 19,999 |
| 2021-12-21 | Clackson Timothy P (President and CEO) | Buy | 2,600 | 9.76 | 25,381 |
| 2021-10-12 | Shakespeare William (See Remarks) | Buy | 625 | 16.00 | 10,000 |
| 2021-10-12 | Orbimed Genesis Gp Llc (10% Owner) | Buy | 625,000 | 16.00 | 10,000,000 |
| 2021-10-12 | Rock Springs Capital Llc (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2021-10-12 | Paster Anne-mari (Other) | Buy | 187,500 | 16.00 | 3,000,000 |
| 2021-10-12 | Gordon Carl L (Director) | Buy | 625,000 | 16.00 | 10,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of THRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Theseus Pharmaceuticals, Inc. (symbol THRX, CIK number 1745020) see the Securities and Exchange Commission (SEC) website.